MRI Interventions, Inc. (OTCQB:MRIC) today announced that clinical outcomes and technical results regarding the application of its ClearPoint(R) Neuro Intervention System in "asleep" deep brain stimulation (DBS) surgery will be presented during the 2013 Annual Meeting of the Congress of Neurological Surgeons (CNS) in San Francisco, California, October 18-23, 2013.

Dr. Jill Ostrem, neurologist at University of California, San Francisco (UCSF), and Dr. Fiona Gupta, neurologist at Hackensack University Medical Center (HUMC), will present clinical outcomes from both centers at the ClearPoint Update reception on Monday, October 21, hosted by MRI Interventions at the Palace Hotel. Dr. Gupta will report on long-term clinical outcomes of asleep DBS with the ClearPoint platform at HUMC, and Dr. Ostrem's presentation will cover preliminary data on clinical outcomes from UCSF. In addition, prominent neurosurgeons will discuss their experiences and technical aspects of the ClearPoint System for a variety of neurosurgical applications, including asleep DBS, focal laser ablation and drug delivery.

During the Original Science Program on Wednesday, October 23, Dr. Paul Larson, neurosurgeon at UCSF, will present long-term accuracy results from a prospective study of 60 patients who underwent asleep DBS with the ClearPoint platform at UCSF between August 2010 and March 2013 in his talk, "Application Accuracy of a Second Generation Interventional MRI Stereotactic Platform: Initial Experience in 101 DBS Electrode Implantations."

MRI Interventions' newest product line extension designed to drive minimally invasive neurosurgical solutions -- the next-generation
SmartFrame(R) XG Exchangeable Guide System -- will also be on display during the conference. Conference attendees are invited to visit Booth
#1652 during the meeting to learn about the new system. Visitors to the booth can also explore an interactive presentation detailing the ClearPoint System's unique suitability for an array of neurosurgical applications.